The COVID-19 pandemic continues to demonstrate the importance of public health screening. My talk will draw upon the body of research that my collaborators and I have conducted in a variety of screening contexts, ranging from newborn screening for genetic disorders to population-level infectious disease screening, including COVID-19. I will discuss the challenges and opportunities for operations researchers.